TOPIC CENTER
818 Articles
Updated Oct 6, 2026
Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
Funding & InvestmentsTeva to Launch Humira Biosimilar Amid Mixed Q1 Results
4 min read • 2 years ago -
Manufacturing ServicesSanofi and Novavax Agree $1.2 Billion Vaccine Alliance
4 min read • 2 years ago -
Funding & InvestmentsAGC Biologics to Let Go of 100 Employees Amid Post-Pandemic Woes
4 min read • 2 years ago -
-
Drug Delivery & PackagingBora Pharmaceutical CEO Backs Innovate Taiwan Program
4 min read • 2 years ago -
-
Funding & InvestmentsIs Pharma Innovation in Europe Falling Behind the US & China?
4 min read • 2 years ago -
Manufacturing & OperationsAdare Adds to High Potency Capabilities in Europe and the US
4 min read • 2 years ago -
Manufacturing ServicesRegeneron and Mammoth Biosciences Forge $100 mn Gene Editing Collaboration
4 min read • 2 years ago -
-
Funding & InvestmentsNovartis Surpasses Q1 Expectations, Raises Full-Year Outlook on Strong Drug Sales
4 min read • 2 years ago -
Funding & InvestmentsWill Pharma Companies Continue to Adopt Orphan Drugs?
4 min read • 2 years ago
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.
